|
|
||||||||
The FASEB Journal, Vol 6, 2332-2337, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
DL Cadena and GN Gill
Department of Medicine, University of California, San Diego, La Jolla 92093-0650.
A major process through which environmental information is transmitted into cells is via activation of protein tyrosine kinases. Receptor tyrosine kinases contain extracellular ligand recognition, single membrane spanning, and cytoplasmic protein tyrosine kinase domains. The cytoplasmic kinase core is flanked by regulatory segments, which in some family members are also inserted into the core kinase domain. Ligand binding initiates receptor signaling from the cell surface. Activated receptors autophosphorylate to remove alternate substrate/inhibitory constraints and to provide loci for assembly of proteins that contain SRC homology regions. Information is transmitted and diffused by tyrosine phosphorylation of the assembled proteins and of cellular substrates that include protein kinases with specificity for serine/threonine residues. Signaling, which is strictly ligand- dependent, is attenuated by down-regulation of receptors and by feed- back inhibitory loops that involve receptor phosphorylation by cellular kinases. The tyrosine kinase receptors are essential for normal growth, development, and reparative processes. Mutations that remove normal regulatory constraints on the approximately 290 amino acid kinase core of these large proteins result in constitutive function and cell transformation.
This article has been cited by other articles:
![]() |
S. Soodvilai, S. H. Wright, W. H. Dantzler, and V. Chatsudthipong Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1057 - F1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Marciniak, A. K. Rishi, F. H. Sarkar, and A. P.N. Majumdar Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells Mol. Cancer Ther., December 1, 2004; 3(12): 1615 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Golestaneh, J. Fan, R. N. Fariss, W.-K. Lo, P. S. Zelenka, and A. B. Chepelinsky Lens Major Intrinsic Protein (MIP)/Aquaporin 0 Expression in Rat Lens Epithelia Explants Requires Fibroblast Growth Factor-induced ERK and JNK Signaling J. Biol. Chem., July 23, 2004; 279(30): 31813 - 31822. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chandrasekher and D. Sailaja Differential Activation of Phosphatidylinositol 3-Kinase Signaling during Proliferation and Differentiation of Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4400 - 4411. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Beutler, C. Hoflich, P. A. Stevens, D. H. Kruger, and S. Prosch Downregulation of the Epidermal Growth Factor Receptor by Human Cytomegalovirus Infection in Human Fetal Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Franch, X. Wang, S. Sooparb, N. S. Brown, and J. Du Phosphatidylinositol 3-Kinase Activity Is Required for Epidermal Growth Factor to Suppress Proteolysis J. Am. Soc. Nephrol., April 1, 2002; 13(4): 903 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Klein, T. A. McCarthy, J. M. Dagle, and J. M. Snyder Antisense Inhibition of Epidermal Growth Factor Receptor Decreases Expression of Human Surfactant Protein A Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 676 - 684. [Abstract] [Full Text] |
||||
![]() |
W. Wu, L. M. Graves, I. Jaspers, R. B. Devlin, W. Reed, and J. M. Samet Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L924 - L931. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. C. Carraway, M. E. Carvajal, and K. L. Carraway Association of the Ras to Mitogen-activated Protein Kinase Signal Transduction Pathway with Microfilaments. EVIDENCE FOR A p185neu-CONTAINING CELL SURFACE SIGNAL TRANSDUCTION PARTICLE LINKING THE MITOGENIC PATHWAY TO A MEMBRANE-MICROFILAMENT ASSOCIATION SITE J. Biol. Chem., September 3, 1999; 274(36): 25659 - 25667. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. GARDIN, C. AUZAN, E. CLAUSER, T. MALHERBE, D. AUNIS, G. CRÉMEL, and P. HUBERT Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action FASEB J, August 1, 1999; 13(11): 1347 - 1357. [Abstract] [Full Text] |
||||
![]() |
R. L. Panek, G. H. Lu, T. K. Dahring, B. L. Batley, C. Connolly, J. M. Hamby, and K. J. Brown In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 569 - 577. [Abstract] [Full Text] |
||||
![]() |
J. M. Klein, L. J. Dewild, and T. A. McCarthy Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L542 - L551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Panek, G. H. Lu, S. R. Klutchko, B. L. Batley, T. K. Dahring, J. M. Hamby, H. Hallak, A. M. Doherty, and J. A. Keiser In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1433 - 1444. [Abstract] [Full Text] |
||||
![]() |
T. C. Holmes, K. Berman, J. E. Swartz, D. Dagan, and I. B. Levitan Expression of Voltage-Gated Potassium Channels Decreases Cellular Protein Tyrosine Phosphorylation J. Neurosci., December 1, 1997; 17(23): 8964 - 8974. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Dahring, G. H. Lu, J. M. Hamby, B. L. Batley, A. J. Kraker, and R. L. Panek J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1446 - 1456. [Abstract] |
||||
![]() |
S. Kataoka, R. Alam, P. K. Dash, and F. M. Yatsu Inhibition of PDGF-Mediated Proliferation of Vascular Smooth Muscle Cells by Calcium Antagonists Stroke, February 1, 1997; 28(2): 364 - 369. [Abstract] [Full Text] |
||||
![]() |
S. Zrihan-Licht, J. Lim, I. Keydar, M. X. Sliwkowski, J. E. Groopman, and H. Avraham Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells J. Biol. Chem., January 17, 1997; 272(3): 1856 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koman, S. Cazaubon, P.-O. Couraud, A. Ullrich, and A. D. Strosberg Molecular Characterization and in Vitro Biological Activity of Placentin, a New Member of the Insulin Gene Family J. Biol. Chem., August 23, 1996; 271(34): 20238 - 20241. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |